• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Biochemical switches identified that could be triggered to treat muscle, brain disorders

Bioengineer by Bioengineer
April 10, 2019
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: St. Jude Children’s Research Hospital

St. Jude Children’s Research Hospital scientists have found that the enzymes ULK1 and ULK2 play a key role in breaking down cell structures called stress granules, whose persistence leads to toxic buildup of proteins that kill muscle and brain cells. Such buildup is central to the pathology of three related diseases: inclusion body myopathy (IBM), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

IBM causes weakness in arm and leg muscles. ALS, also known as Lou Gehrig’s disease, causes paralysis due to the death of nerve cells controlling voluntary muscles. FTD is a form of dementia that damages areas of the brain associated with personality, behavior and language.

Led by St. Jude researcher Mondira Kundu, M.D., Ph.D., an associate member of the St. Jude Department of Pathology, the team published their findings online in the journal Molecular Cell.

Stress granules are biological “storm shelters” that temporarily protect genetic molecules and proteins when the cell’s health is under threat from heat, chemicals or infection. Such granules normally disassemble when the stress is removed, but mutations that cause malfunction in the disassembly machinery can cause them to persist. One such mutation is in a gene called VCP, and the St. Jude researchers found that ULK1/2 is a key activator of VCP. Thus, they believe that drugs to boost those enzymes could help treat the pathology of IBM, ALS and FTD.

The other St. Jude authors are Bo Wang, Brian Maxwell, Joung Hyuck Joo, Youngdae Gwon, James Messing, Ashutosh Mishra, Timothy Shaw, Amber Ward, Honghu Quan, Sadie Miki Sakurada, Shondra Pruett-Miller, Peter Vogel, Hong Joo Kim and Junmin Peng. Co-author Tulio Bertorini is with the University of Tennessee Heath Science Center. Co-author J. Paul Taylor is a Howard Hughes Medical Institute Investigator and chair of the St. Jude Department of Cell and Molecular Biology.

The research was supported by the National Institutes of Health (R01 MH115058, HL114697, R01 GM114260, R35 NS097974), the Robert Packard Center for ALS Research and ALSAC, the fundraising and awareness organization of St. Jude.

###

Media Contact
Corey Carmichael
[email protected]

Original Source

http://www.stjude.org/ulk1-ulk2-stress-granules

Related Journal Article

http://dx.doi.org/10.1016/j.molcel.2019.03.027

Tags: BiologyCell BiologyDevelopmental/Reproductive BiologyMedicine/Health
Share14Tweet8Share2ShareShareShare2

Related Posts

Unraveling Complement Genes’ Impact on Pancreatic Cancer

November 29, 2025

New Measure Identifies Language Delays in Toddlers

November 29, 2025

Burnout, Satisfaction, and Care Rationing in Nursing

November 29, 2025

Infant Antibiotic Use Linked to Childhood Overweight Risk

November 29, 2025
Please login to join discussion

POPULAR NEWS

  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    203 shares
    Share 81 Tweet 51
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    120 shares
    Share 48 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    105 shares
    Share 42 Tweet 26
  • MoCK2 Kinase Shapes Mitochondrial Dynamics in Rice Fungal Pathogen

    64 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling Complement Genes’ Impact on Pancreatic Cancer

New Measure Identifies Language Delays in Toddlers

Burnout, Satisfaction, and Care Rationing in Nursing

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 70 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.